文献速递临床生化临床免疫

Elecsys®与Kryptor免疫分析法检测sFlt-1和PlGF用于子痫前期诊断辅助的可比性研究

Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
PubMed 文献 · Clin Chem Lab Med · 2019-01-01

本研究对113例子痫前期/HELLP孕妇和270例对照的血清样本,用Elecsys®和Kryptor免疫分析法检测sFlt-1和PlGF并计算比值,发现两种方法虽高度相关但sFlt-1/PlGF和PlGF结果差异显著,Elecsys®验证的cut-off不能直接用于Kryptor。

要点

  • Elecsys®与Kryptor检测sFlt-1和PlGF高度相关,但PlGF结果Kryptor约低20%。
  • sFlt-1/PlGF比值在两种方法间差异显著,cut-off不可互换。
  • 早发型子痫前期≥85 cut-off下,Elecsys®和Kryptor灵敏度/特异度分别为88.1%/100.0%和90.5%/96.2%。

核心结论

  • Elecsys®与Kryptor免疫分析法虽高度相关,但sFlt-1/PlGF和PlGF结果差异显著。
  • Elecsys®验证的sFlt-1/PlGF cut-off不能直接用于Kryptor免疫分析法。

研究设计与样本

  • 病例对照研究,纳入113例子痫前期/HELLP孕妇和270例对照,分析血清样本。
  • 使用Roche Elecsys®和BRAHMS Kryptor免疫分析法检测sFlt-1和PlGF,计算sFlt-1/PlGF比值,并进行Passing-Bablok回归和Bland-Altman图分析。
  • 评估了早发型(≤33周)和晚发型(≥34周)子痫前期的妊娠特异性cut-off(≤33和≥85/≥110)。

主要发现

  • Elecsys®与Kryptor检测sFlt-1和PlGF的Pearson相关系数分别为0.913和0.945。
  • sFlt-1和PlGF的Passing-Bablok回归斜率分别为1.06和0.79,Kryptor PlGF结果约低20%。
  • Elecsys®与Kryptor检测sFlt-1的平均差异(±2SD)为173.13 pg/mL(6237.66, -5891.40),PlGF为-102.71 pg/mL(186.06, -391.48),sFlt-1/PlGF为151.74(1085.11, -781.63)。
  • 早发型子痫前期(20+0至33+6周)使用sFlt-1/PlGF ≥85 cut-off时,Elecsys®和Kryptor的灵敏度/特异度分别为88.1%/100.0%和90.5%/96.2%。
  • 晚发型子痫前期(≥34+0周)使用≥110 cut-off时,Elecsys®和Kryptor的灵敏度/特异度分别为51.3%/96.5%和78.9%/90.1%。

关键数值与推荐

  • sFlt-1/PlGF ≥85 cut-off用于早发型子痫前期(20+0至33+6周)辅助诊断。
  • sFlt-1/PlGF ≥110 cut-off用于晚发型子痫前期(≥34+0周)辅助诊断。
  • 上述cut-off基于Elecsys®免疫分析法验证,不适用于Kryptor免疫分析法。

临床怎么用

  • 临床解读sFlt-1/PlGF比值时需注意检测方法,不能将Elecsys®的cut-off直接用于Kryptor。
  • 同一医疗机构应固定使用同一种免疫分析法进行系列监测。

局限性

  • 本研究为病例对照设计,可能存在选择偏倚。
  • 样本来自单中心,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background For pregnant women with suspected preeclampsia, the soluble fms-like tyrosine-kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio is a biomarker to aid diagnosis. We performed method comparisons between Elecsys® and Kryptor sFlt-1 and PlGF immunoassays and assessed the diagnostic performance for preeclampsia. Methods Serum samples from a case-control study involving 113 pregnant women with preeclampsia/elevated liver enzymes and low platelet count (HELLP) and 270 controls were analyzed. sFlt-1 and PlGF were measured using Roche Elecsys® and BRAHMS Kryptor sFlt-1/PlGF immunoassays. The sFlt-1/PlGF ratios were calculated, and Passing-Bablok regression/Bland-Altman plots were performed. Gestation-specific cut-offs, ≤33 and ≥85/≥110, were assessed. Results Mean (±2 standard deviation [SD]) differences between the Elecsys® and Kryptor values were: sFlt-1, 173.13 pg/mL (6237.66, -5891.40); PlGF, -102.71 pg/mL (186.06, -391.48); and sFlt-1/PlGF, 151.74 (1085.11, -781.63). The Elecsys® and Kryptor immunoassays showed high correlation: Pearson's correlation coefficients were 0.913 (sFlt-1) and 0.945 (PlGF). Slopes were 1.06 (sFlt-1) and 0.79 (PlGF), resulting in ~20% lower values for Kryptor PlGF. Sensitivities and specificities using the sFlt-1/PlGF ≥85 cut-off for early-onset preeclampsia (20 + 0 to 33 + 6 weeks) were 88.1%/100.0% (Elecsys®) and 90.5%/96.2% (Kryptor), respectively, and using the ≥110 cut-off for late-onset preeclampsia (≥34 + 0 weeks) were 51.3%/96.5% (Elecsys®) and 78.9%/90.1% (Kryptor), respectively. Using Elecsys® and Kryptor sFlt-1/PlGF, 0% and 3.8% of women, respectively, were falsely ruled-in for early-onset, and 3.5% and 9.9%, respectively, for late-onset preeclampsia. Conclusions Despite high correlation between the Elecsys® and Kryptor immunoassays, we observed significant differences between sFlt-1/PlGF and PlGF results. Therefore, sFlt-1/PlGF cut-offs validated for Elecsys® immunoassays are not transferable to Kryptor immunoassays.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Stepan H, Hund M, Dilba P, et al. Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable? Clin Chem Lab Med. 2019. PMID: 31323000. doi:10.1515/cclm-2018-1228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。